The NBSGW RIP-DTR Mouse: An Integrated Platform for Diabetes Induction, Human Immune Reconstitution and Transplantation Studies
Chamberlain, C. S.; Kapadia, D.; Abad Santos, E.; Huang, L.; Holm, A.; Leavens, C.; Palwasha Khan, A.; Gorski, K. M.; Steck, C. C.; Mikat, A. S.; Tremmel, D. M.; Chlebeck, P.; Talerico, K.; Estrada, E.; McIntosh, B.; Brown, M. E.; Sackett, S. D.; Odorico, J. S.
Show abstract
Using toxin receptor-mediated cell ablation, a diabetes mouse model was generated that supports engraftment of human hematopoietic stem/progenitor cells (HSPCs) without the need for irradiation. The NBSGW immunodeficient strain was crossed with the NSG RIP-DTR which carries the diphtheria toxin receptor (hDTR) under the control of the rat insulin promoter to generate the NBSGW RIP-DTR mouse. This model enables controlled {beta}-cell ablation, robust human immune system reconstitution without myeloablative conditioning, and evaluation of human immune-mediated graft rejection within a single platform. NBSGW RIP-DTR mice exhibited reproducible and titratable diabetes induction, supported durable human islet engraftment and glycemic correction, and retained efficient human hematopoietic reconstitution comparable to the parental NBSGW strain. In humanized mice, diphtheria toxin-mediated diabetes induction was well tolerated and enabled assessment of human immune responses to allogeneic islet grafts. Collectively, these findings establish the NBSGW RIP-DTR mouse as an integrated and clinically relevant platform for studying {beta}-cell replacement therapies and human immune-mediated graft rejection. Article HighlightsO_LICurrent preclinical models do not simultaneously support controlled diabetes induction, human islet transplantation, and durable human immune reconstitution without irradiation. C_LIO_LIThis study asked whether the NBSGW RIP-DTR mouse could integrate diphtheria toxin-mediated {beta}-cell ablation with irradiation-free humanization in a single platform. C_LIO_LINBSGW RIP-DTR mice demonstrated reproducible diabetes induction, supported functional human islet engraftment, and retained robust human hematopoietic reconstitution comparable to parental strains. C_LIO_LIThese findings establish the NBSGW RIP-DTR model as a clinically relevant platform for studying {beta}-cell replacement and human immune response to islet allografts, xenografts and stem cell-derived islets. C_LI
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Donor Macrophage Depletion Permits Post-Transplant Tolerance Induction in a Murine Islet Transplant Model 95%
- Th1/17 Cells Infiltrate Murine Cytomegalovirus-Infected Renal Allografts via Virus-Induced CCL20 and Promote Th1 Cells through IL-17A. 93%
- Deceased donor kidney degradomics indicates cytoskeletal proteolytic alterations impacting post-transplant function 90%
Similar papers in this journal
Similar papers in this journal
- Natural protection from type 1 diabetes in Non Obese Diabetic (NOD) mice is characterised by a unique pancreatic islet phenotype 93%
- Polysaccharide A-dependent opposing effects of mucosal and systemic exposures to human gut commensal Bacteroides fragilis in type 1 diabetes 92%
- Microvascular homeostasis is compromised in pancreatic islets in a mouse model of beta cell loss and low-grade inflammation 92%
Similar papers in this journal
- Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice 92%
- Antibody-drug conjugates targeting CD45 plus Janus kinase inhibitors effectively condition for allogeneic hematopoietic stem cell transplantation 92%
- Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.